Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
New England Journal of Medicine, 09/17/09
Connolly SJ et al. – In patients with atrial fibrillation, dabigatran given at a dose of 110 mg was associated with rates of stroke and systemic embolism that were similar to those associated with warfarin, as well as lower rates of major hemorrhage. Dabigatran administered at a dose of 150 mg, as compared with warfarin, was associated with lower rates of stroke and systemic embolism but similar rates of major hemorrhage.
Related Articles
Atrial Fibrillatory Wall Motion and Degree of Atrial Remodeling in Patients with Atrial Fibrillation: A Tissue Velocity Imaging Study
Journal of Cardiovascular Electrophysiology, 10/28/09
Relevance Score: 70%
Catheter Ablation of Supraventricular Arrhythmias and Atrial Fibrillation
American Family Physician, 11/12/09
Relevance Score: 69%
Sudden atrial fibrillation associated with acute alcohol ingestion and cor triatriatum
Baylor UMC Proceedings, 10/27/09
Relevance Score: 69%
Oral anticoagulant therapy safely prevented stroke in older patients with atrial fibrillation
Evidence-Based Medicine, 10/26/09
Relevance Score: 69%
Glucocorticoid Use and Risk of Atrial Fibrillation or Flutter
Archives of Internal Medicine, 10/14/09
Relevance Score: 69%
Today in Arrhythmias/EP...keeping you current
Receive free subspecialty "5-minute updates" via email
Pain perception during esophageal warming due to radiofrequency catheter ablation in the left atrium
Journal of Interventional Cardiac Electrophysiology , 12/11/09
Recent Caffeine Ingestion Reduces Adenosine Efficacy in the Treatment of Paroxysmal Supraventricular Tachycardia
Academic Emergency Medicine, 12/11/09
Safety and feasibility of catheter ablation for atrioventricular nodal re-entrant tachycardia without fluoroscopic guidance
Heart Rhythm, 12/11/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study
Clinical Drug Investigation, 12/11/09
Valsartan plus hydrochlorothiazide for first-line therapy in hypertension
Expert Review of Cardiovascular Therapy , 12/11/09
Doxorubicin Cardiomyopathy
Cardiology, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


